SS-31 (also known as Elamipretide) is a synthetic peptide that is designed to target and improve mitochondrial function. It is known for its potential to protect mitochondria from oxidative stress and damage, which is critical because mitochondrial dysfunction is associated with a variety of age-related diseases and conditions, including neurodegenerative diseases, heart disease, and muscle disorders.
SS-31 works by selectively binding to the inner mitochondrial membrane and stabilizing mitochondrial membranes, helping to reduce mitochondrial damage, improve energy production, and enhance cell function. It has been investigated for its potential therapeutic effects in conditions like mitochondrial myopathy, Alzheimer’s disease, and other disorders where mitochondrial dysfunction plays a role.
The peptide is still primarily in the research and clinical trial phase, with promising results in preclinical studies suggesting it could be beneficial for treating conditions associated with mitochondrial dysfunction.
